PageOverview.com
 

Domains targeting keyword e-prescribing system

Keyword e-prescribing system was used in the provided list of websites.

 
Number of websites/domains displayed: 41
Results found: 41
 

Similar searches:

 

Websites discovered:

Treatment with INVOKANA® (canagliflozin)
http://pageoverview.com/website-report/invokana.com
Learn about INVOKANA® (canagliflozin), an SGLT2 inhibitor that helps lower blood sugar in adults. See full prescribing and safety information.
  • Expected expiration: August 15th in 2017
  • Creation date: August 15th in 2012
  • Renew date: August 11th in 2016
  • Google Analytics: 1724827-37
VELCADE® (bortezomib) Official Website
http://pageoverview.com/website-report/velcade.com
The Official Website for VELCADE® (bortezomib).
  • Expected expiration: March 18th in 2018
  • Creation date: March 18th in 2002
  • Renew date: March 14th in 2017
  • Google Analytics: 7032150-3
For Healthcare Professionals | Effient® tablets
http://pageoverview.com/website-report/effienthcp.com
Find information for physicians & healthcare professionals about Effient® (prasugrel) tablets. See full Prescribing & Safety Information including Boxed Warning.
  • Expected expiration: May 21st in 2018
  • Creation date: May 21st in 2008
  • Renew date: May 17th in 2017
Treatment & Support | PREZCOBIX® (darunavir 800 mg/cobicistat 150 mg)
http://pageoverview.com/website-report/prezcobix.com
Learn how treatment with once-daily PREZCOBIX® (darunavir 800 mg/cobicistat 150 mg) may affect CD4+ cell count. See full Prescribing & Safety info.
  • Expected expiration: June 10th in 2018
  • Creation date: June 10th in 2014
  • Renew date: May 14th in 2017
  • Google Analytics: 2050685-23
PARAGARD® (intrauterine copper contraceptive) | Home
http://pageoverview.com/website-report/paragard.com
Learn about PARAGARD—the only hormone-free IUD that’s over 99% effective. It helps prevent pregnancy for up to 10 years, but your HCP can remove it at any time. Please see Important Safety Information and full Prescribing Information on this website.
  • Expected expiration: December 11th in 2017
  • Creation date: December 12th in 1997
  • Renew date: December 6th in 2016
Stage IA & IB mycosis fungoides–type cutaneous t-cell lymphoma | VALCHLOR (mechlorethamine)
http://pageoverview.com/website-report/valchlor.com
Information for patients about an FDA-approved topical prescription medicine for Stage IA & IB mycosis fungoides–type cutaneous t-cell lymphoma. Find important safety information medication guide and prescribing information.
  • Expected expiration: October 25th in 2017
  • Creation date: October 25th in 2011
  • Renew date: October 21st in 2016
  • Google Analytics: 55588032-1
INVOKANA® (canagliflozin) Treatment | HCP
http://pageoverview.com/website-report/invokanahcp.com
Learn more about a once-daily treatment option that can help lower blood glucose in adults. See full Prescribing and safety info.
  • Expected expiration: August 14th in 2017
  • Creation date: August 14th in 2012
  • Renew date: May 12th in 2017
  • Google Analytics: 70816641-5
SRS Pharmacy Systems
http://pageoverview.com/website-report/srspharmacy.com
SRS Pharmacy Systems is an integrated, EPCS certified, Pharmacy Management software and systems provider servicing pharmacies throughout the United States.
  • Expected expiration: January 20th in 2019
  • Creation date: January 20th in 2003
  • Renew date: January 14th in 2016
  • Google Analytics: 69032028-1
STIVARGA (regorafenib) | Patient Website
http://pageoverview.com/website-report/stivarga-us.com
Learn about STIVARGA (regorafenib). Visit STIVARGA-US.com to see full safety and prescribing information, including boxed warning.
  • Expected expiration: June 6th in 2017
  • Creation date: June 6th in 2012
  • Renew date: June 3rd in 2015
Minivelle® (estradiol transdermal system) for hot flashes
http://pageoverview.com/website-report/minivelle.com
Minivelle (estradiol transdermal system) is indicated for the treatment of hot flashes in menopause. Read the full Prescribing Information, including Boxed WARNING.
  • Expected expiration: August 1st in 2018
  • Creation date: August 1st in 2012
  • Renew date: June 2nd in 2015
  • Google Analytics: 37162889-1
Complete Pharmacy Solutions & Best Pharmacy POS System|Myezpharmacy
http://pageoverview.com/website-report/myezpharmacy.org
Myezpharmacy provides complete pharmacy solutions with pharmacy POS system & 24 hour services for healthcare solutions with advanced technology that useful for physicians and pharmacist
  • Expected expiration: December 22nd in 2018
  • Creation date: December 22nd in 2015
  • Renew date: November 28th in 2016
  • Google Analytics: 77199495-1
  • Google Plus Account: +MyEzPharmacy
SYMBICORT® (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol For Health Care Professionals
http://pageoverview.com/website-report/symbicorttouchpoints.com
Official HCP site for SYMBICORT, an asthma and COPD treatment, providing information on the inhaler, side effects, dosage and prescribing information.
  • Expected expiration: October 15th in 2017
  • Creation date: October 15th in 2009
  • Renew date: October 11th in 2016
Adempas (riociguat) - Official Site
http://pageoverview.com/website-report/adempas-us.com
Adempas (riociguat). Visit Adempas-US.com to see full safety and prescribing information including boxed warning. Learn about Adempas and the Aim Patient Support Program.
  • Expected expiration: March 25th in 2019
  • Creation date: March 25th in 2013
  • Renew date: March 21st in 2017
Plaque Psoriasis & Psoriatic Arthritis | STELARA® (ustekinumab)
http://pageoverview.com/website-report/stelarainfo.com
Learn about moderate to severe plaque psoriasis & active psoriatic arthritis treatment STELARA®. See Full Prescribing Info & Important Safety Information.
  • Expected expiration: December 4th in 2017
  • Creation date: December 4th in 2008
  • Renew date: May 13th in 2017
  • Google Analytics: 1863405-87
Tresiba® Long-Acting Insulin | Tresiba® (insulin degludec injection 100 Units/mL, 200 Units/mL)
http://pageoverview.com/website-report/tresiba.com
Once-daily Tresiba® is a long-acting insulin used to control high blood sugar in adults and children as young as 1 year old with diabetes. Read important safety and prescribing info on this page.
  • Expected expiration: August 27th in 2017
  • Creation date: August 27th in 2010
  • Renew date: September 24th in 2015
ORENCIA® (abatacept) | Official Patient Website
http://pageoverview.com/website-report/orencia.com
The ORENCIA® (abatacept) site provides Important Safety Information and Full Prescribing Information. Visit orencia.bmscustomerconnect.com to learn more
  • Expected expiration: January 24th in 2018
  • Creation date: January 24th in 2001
  • Renew date: January 20th in 2017
HIV-1 Treatment l Atripla® (efavirenz/emtricitabine/tenofovir disoproxil fumarate)
http://pageoverview.com/website-report/atripla.com
Learn about ATRIPLA® (efavirenz/emtricitabine/tenofovir disoproxil fumarate) an HIV-1 treatment. See Safety Info including Boxed WARNING and Full Prescribing Info.
  • Expected expiration: March 29th in 2018
  • Creation date: March 29th in 2005
  • Renew date: March 2nd in 2017
TOPAMAX® (topiramate) Product Information
http://pageoverview.com/website-report/topamax.com
Discover prescription TOPAMAX® (topiramate) for migraine prevention in adults and find a coupon. See Important Safety Information & full Prescribing Information.
  • Expected expiration: June 7th in 2017
  • Creation date: June 8th in 1998
  • Renew date: June 3rd in 2016
  • Google Analytics: 533766-1
Official Healthcare Professional Site | ORENCIA® (abatacept)
http://pageoverview.com/website-report/orenciahcp.com
Our site offers info for healthcare providers treating patients with moderate to severe rheumatoid arthritis. See Important Safety Info and Prescribing Info.
  • Expected expiration: March 2nd in 2018
  • Creation date: March 2nd in 2015
  • Renew date: February 26th in 2017
Choose FETZIMA® (levomilnacipran) ER Capsules to Treat MDD
http://pageoverview.com/website-report/fetzima.com
FETZIMA® is FDA approved for the treatment of Major Depressive Disorder in adults. See risk info, including Boxed Warning & full Prescribing Information.
  • Expected expiration: February 28th in 2019
  • Creation date: February 29th in 2012
  • Renew date: March 23rd in 2017
SleepView® Web Portal
http://pageoverview.com/website-report/lucyme.com
Our HIPAA compliant and secure Web Portal offers prescribing physicians online access to patients' sleep test raw data, scoring by registered polysomnographic technologists, and professional interpretation with treatment recommendations by board-certified sleep physicians.
  • Expected expiration: January 21st in 2018
  • Creation date: January 21st in 2009
  • Renew date: January 22nd in 2017
Xeomin® (incobotulinumtoxinA) Official site
http://pageoverview.com/website-report/xeomin.com
Xeomin® (incobotulinumtoxinA). Official Site. Learn more about XEOMIN. Click to see full Prescribing Information, including Boxed WARNING.
  • Expected expiration: December 16th in 2020
  • Creation date: December 16th in 2000
  • Renew date: June 28th in 2015
  • Google Analytics: 19397161-1
Homepage - PENNSAID - Official Site
http://pageoverview.com/website-report/pennsaid.com
PENNSAID (diclofenac sodium topical solution) official site. Click to see full safety and prescribing information, including boxed warning.
  • Expected expiration: February 1st in 2021
  • Creation date: February 1st in 2000
  • Renew date: December 29th in 2014
  • Google Analytics: 9066629-22
Official Site | Effient® (prasugrel)
http://pageoverview.com/website-report/effient.com
Discover Effient®, a treatment option to be taken with aspirin for ACS patients treated with angioplasty. See Prescribing, Safety Info, & Boxed Warning.
  • Expected expiration: July 24th in 2017
  • Creation date: July 24th in 2006
  • Renew date: July 20th in 2016
Long-Term Bipolar I Disorder Treatment | RISPERDAL® CONSTA®
http://pageoverview.com/website-report/risperdalconsta.com
Learn about RISPERDAL® CONSTA® (risperidone) and how it can help those living with Bipolar I Disorder. See Safety & full Prescribing Information.
  • Expected expiration: October 17th in 2017
  • Creation date: October 17th in 2001
  • Renew date: October 13th in 2016
  • Google Analytics: 614896-8
Merck.com | Products | Prescription-Products | Prescription Products & Prescribing Information
http://pageoverview.com/website-report/propecia.com
  • Expected expiration: September 27th in 2018
  • Creation date: September 28th in 1996
  • Renew date: August 26th in 2016
VIIBRYD® (vilazodone HCl) For Major Depressive Disorder
http://pageoverview.com/website-report/viibryd.com
Learn about VIIBRYD®, and how it may help you manage your condition. See risk info, including Boxed Warning & full Prescribing Information.
  • Expected expiration: August 12th in 2018
  • Creation date: August 12th in 2010
  • Renew date: March 23rd in 2017
BOTOX® (onabotulinumtoxinA) for Medical Professionals
http://pageoverview.com/website-report/botoxmedical.com
Access exclusive BOTOX® training resources and learn about BOTOX® indications. See full safety and Prescribing Information including Boxed Warning.
  • Expected expiration: September 30th in 2020
  • Creation date: September 30th in 2005
  • Renew date: January 8th in 2015
Butrans® (buprenorphine) Transdermal System CIII | Official HCP Site
http://pageoverview.com/website-report/butrans.com
Discover Butrans, a Schedule III, extended-release opioid. See Full Prescribing Info, Safety Info & Boxed Warning.
  • Expected expiration: July 10th in 2018
  • Creation date: July 10th in 2003
  • Renew date: June 9th in 2016
AZILECT® (rasagiline tablets) Prescribing Information
http://pageoverview.com/website-report/azilect.com
See the prescribing information for AZILECT® (rasagiline tablets).
  • Expected expiration: October 20th in 2017
  • Creation date: October 20th in 2003
  • Renew date: September 25th in 2016
TRELSTAR® (triptorelin pamoate for injectable suspension) | Palliative Treatment for Advanced Prostate Cancer
http://pageoverview.com/website-report/trelstar.com
TRELSTAR® (triptorelin pamoate for injectable suspension) is a palliative treatment for men with advanced prostate cancer. View Important Safety Information and full Prescribing Information on website. Learn more about Trelstar®’s MOA, efficacy, dosing, and administration.
  • Expected expiration: July 17th in 2017
  • Creation date: July 17th in 2002
  • Renew date: March 21st in 2017
Synthroid® (levothyroxine sodium tablets, USP) | Official Website
http://pageoverview.com/website-report/synthroid.com
Learn about Synthroid® (levothyroxine sodium tablets, USP) and click for full safety and prescribing information, including important safety information.
  • Expected expiration: December 1st in 2017
  • Creation date: December 2nd in 1996
  • Renew date: February 17th in 2017
Janssen CarePath™ Patient Support Program | XARELTO® (rivaroxaban)
http://pageoverview.com/website-report/xareltocarepath.com
Register for the Janssen CarePath Support Program to find valuable cost and savings information. See full Prescribing & Safety Info including Boxed Warnings.
  • Expected expiration: March 17th in 2019
  • Creation date: March 17th in 2011
  • Renew date: March 13th in 2017
  • Google Analytics: 70816641-13
Interactive Health Partner � Health and Fitness Management
http://pageoverview.com/website-report/interactivehealthpartner.com
The Interactive Health Partner is a comprehensive set of health management tools for prescribing, tracking, and monitoring members' health & fitness activity.
  • Expected expiration: January 4th in 2018
  • Creation date: January 4th in 2007
  • Renew date: March 4th in 2017
XARELTO® (rivaroxaban) | Prescription Blood Thinner
http://pageoverview.com/website-report/xarelto-us.com
Learn about prescription blood thinner XARELTO® including treatment information and cost. See Full Prescribing & Safety Info including Boxed Warnings.
  • Expected expiration: March 16th in 2019
  • Creation date: March 16th in 2009
  • Renew date: March 12th in 2017
  • Google Analytics: 70816641-13
Teva's COPAXONE® (glatiramer acetate injection) | Official Site
http://pageoverview.com/website-report/copaxone.com
Official site for COPAXONE® (glatiramer acetate injection) from Teva. Includes use, safety, prescribing information and patient resources.
  • Expected expiration: March 1st in 2018
  • Creation date: February 28th in 1997
  • Renew date: February 28th in 2017
e-Prescribing Integration and Software | DoseSpot
http://pageoverview.com/website-report/dosespot.com
The DoseSpot e-Prescribing platform is your company's prescription to e-Prescribing. Get Surescripts certified as quickly as possible.
  • Expected expiration: September 10th in 2018
  • Creation date: September 10th in 2007
  • Renew date: August 12th in 2015
  • Google Analytics: 46021048-1
e-Prescribing Software: MDToolbox
http://pageoverview.com/website-report/mdtoolbox.com
MDToolbox e-Prescribing software is designed to easily integrate with EHRs/EMRs/PMs. Add a Surescripts, Meaningful Use and EPCS Certified eRx module into your system with ease.
  • Expected expiration: May 6th in 2019
  • Creation date: May 6th in 2011
  • Renew date: May 7th in 2017
  • Google Analytics: 31829479-1
  • Google Plus Account: +MdtoolboxRx
COUMADIN® | What is COUMADIN®
http://pageoverview.com/website-report/coumadin.com
Learn about COUMADIN®, a prescription medicine. Read Important Safety Information and access Prescribing Information including BOXED WARNING and Medication Guide.
  • Expected expiration: January 19th in 2018
  • Creation date: January 18th in 1997
  • Renew date: January 15th in 2017
SUBOXONE® (buprenorphine and naloxone) Sublingual Film (CIII)
http://pageoverview.com/website-report/suboxone.com
SUBOXONE Film along with counseling and psychosocial support may help you—or someone you care about—manage opioid dependence. See full safety and prescribing information.
  • Expected expiration: April 1st in 2018
  • Creation date: April 1st in 1999
  • Renew date: March 28th in 2017
  • Google Analytics: 32458541-1
Patient Web site for AMRIX® (Cyclobenzaprine Hydrochloride Extended‐Release Capsules)
http://pageoverview.com/website-report/amrix.com
Learn about AMRIX® (Cyclobenzaprine Hydrochloride Extended‐Release Capsules) for the treatment of muscle spasm due to acute, painful musculoskeletal conditions. AMRIX is a prescription medicine used along with rest and physical therapy to help treat muscle spasm due to acute, painful musculoskeletal problems. AMRIX should only be used for up to 2 or 3 weeks. It is not known if AMRIX is effective when used for longer periods. It is not known if AMRIX is safe and effective in children. Do not take AMRIX if you: • are allergic to cyclobenzaprine or any of the components of AMRIX. Talk to your healthcare provider or get medical help right away if you have symptoms of an allergic reaction such as difficulty breathing, hives, swelling of your face or tongue, or itching • are taking certain antidepressants known as monoamine oxidase (MAO) inhibitors, or it has been 14 days or less since you stopped taking a MAO inhibitor. Ask your healthcare provider or pharmacist for a list of these medicines if you are not sure • have had a recent heart attack • have heart rhythm problems (arrhythmias) • have heart failure • have an overactive thyroid (hyperthyroidism). Talk to your healthcare provider before taking this medicine if you have any of the conditions listed above. You should not drink alcohol until you know how AMRIX affects you. Taking AMRIX with alcohol or other medicines that depress your central nervous system can slow your thinking and physical response times. Do not drive, operate machinery, or do other dangerous activities until you know how AMRIX affects you. AMRIX may cause serious side effects that may lead to heart attack or stroke. Call your healthcare provider immediately or go to the nearest hospital emergency room if you have: • irregular or abnormal heartbeats (arrhythmias) • fast heartbeat (tachycardia). Serotonin syndrome is a serious medical condition that may happen when AMRIX is taken with certain other medicines. Call your healthcare provider right away or go to the nearest hospital emergency room if you become severely ill and have some or all of these symptoms: • agitation, hallucinations, coma, or other changes in mental status • coordination problems or muscle twitching (overactive reflexes) • fast heartbeat, high or low blood pressure • sweating or fever • nausea, vomiting, or diarrhea • muscle stiffness or tightness. The most common side effects of AMRIX include dry mouth, dizziness, fatigue, constipation, nausea, upset stomach, and drowsiness. Tell your healthcare provider if you get any side effect that bothers you or that does not go away. These are not all the possible side effects of AMRIX. For more information, talk to your healthcare provider or pharmacist. Please see the Patient Information Leaflet within the accompanying Full Prescribing Information.
  • Expected expiration: November 20th in 2017
  • Creation date: November 20th in 2001
  • Renew date: November 15th in 2016
  • Google Analytics: 38345010-1
0.0466 // 2024-05-30 04:54:39
All Rights reserved 2018 © PageOverview.com